Nhan Ho

NANOGEN BIOPHARMACEUTICAL is a leading company that is doing research and development of active Biopharmaceutical ingredients (APIs), and specific therapeutic injections in Asia Pacific region, based on advance in recombinant DNA and protein technologies. Nanogen offers a variety of gene-to-therapy biopharmaceuticals for the treatment of hepatitis B, hepatitis C, anemia due to chronic renal failure, oncology, etc. Our departments and facilities are integrated in the area of 15 000 square meters, located in Saigon Hi-tech Park Ho chi Minh City Vietnam. We research, develop, manufacture and market a wide range of therapeutic injection products under the strict compliance with current GMP and tight QC/QA procedures. Nanogen’s team consists of high-qualified scientists and graduates in diversity of biotechnology, pharmaceutical and healthcare. We have an international business network with the aim to produce high quality, affordable biotherapeutics.